Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…C 2021 criteria, while nine met ILE criteria. During follow-up, hydroxychloroquine was used in 14 patients, csDMARDs in 9, JAK inhibitors in 10, a…
…otic and/or immunosuppressive therapy; post-VHD treatments were aspirin (48.6%), anticoagulants (50%), hydroxychloroquine (86.1%), gluc…
…frequently azathioprine (n=10), mycophenolate mofetil (n=8), or methotrexate (n=5). RTX was administered in a median of three cycles (2–6) o…
… Due to therapeutic failure with rituximab, she was switched to anifrolumab. Twelve days after the first infusion, she developed a painful …
…d with other systemic manifestations, except in two cases where rituximab was required for refractory thrombocytopenia.Conclusions Thromb…
…nd plasma exchange was given without efficacy so treatment with obinutuzumab plus cyclophosphamide was initiated, with gradual neurological …
…d ( table 1). Case 1: A 27-year-old female with SLE, who was on hydroxychloroquine (HCQ) and rituximab (RTX), was admitted with an axillary absces…
… (SLE) is an autoimmune disease driven by B-cell dysregulation. Rituximab (RTX) depletes B cells through complement-dependent cytotoxicit…
…ntibodies are associated with response to rituximab followed by belimumab. This study aimed to investigate IgA2+ B cells in SLE using 5’ …
…and 4%-13%, respectively); biologic use was primarily off-label rituximab.…
…ntenance in 69% of cases, a total of 14.5% of patients received rituximab as a rescue therapy, while 20.3% were treated with CYC as a rei…